Abstract
MRSA is a significant cause of HAI and impacts the patients' morbidity, mortality and healthcare costs. The increased cost associated with an HAI has been documented. An analysis of 55 studies determined that a MRSA HAI cost $35,367. In New Jersey, legislation mandated hospitals to perform active surveillance culture (ASC) for MRSA in an intervention unit. A facility risk assessment determined the intervention unit to be a twelve bed surgical intensive care unit (SICU). The objective of this study is to compare the cost and incidence of healthcare associated (HA) MRSA between two intensive care units over 30 months.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
